Brain pacemaker in Alzheimer disease
| dc.contributor.author | Eltajouri, Ayatullah Salem Muftah | |
| dc.date.accessioned | 2019-04-06T08:28:47Z | |
| dc.date.available | 2019-04-06T08:28:47Z | |
| dc.date.issued | 2018-04-15 | |
| dc.identifier.uri | http://repository.limu.edu.ly/handle/123456789/653 | |
| dc.description | Alzheimer's disease is the most common form of degenerative dementia, affecting more than 5 million American. By 2050, this number could rise as high as 16 million, according the Alzheimer's association. The disease which have no cure, and is not easily managed becomes progressively disabling with loss of memory, cognition and worsening of behavioral function, in addition to a gradual loss of independent functioning. Researches have studied how using and implant linked to a pacemaker for the brain can help Alzheimer's patients to retain cognitive, behavioral and functional abilities longer while also improving quality of life | en_US |
| dc.description.abstract | For the first time ever, thin electrical wires were surgically implanted into the frontal lobes of the brains of patients with Alzheimer's disease, this device is called Deep brain stimulating (DBS). The deep brain stimulation (DBS) implant is similar to a cardiac pacemaker device, except that the pacemaker wires are implanted in the brain rather than the heart. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | faculty of Basic Medical Science - Libyan International Medical University | en_US |
| dc.rights | Attribution 3.0 United States | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
| dc.title | Brain pacemaker in Alzheimer disease | en_US |
| dc.type | Other | en_US |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as Attribution 3.0 United States